News
The first procedure in the world designed to treat a patient using a bioengineered external liver was recently performed by a team at Intermountain Medical Center.
REDWOOD CITY, Calif., June 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...
That slowdown is having an impact on employment. In fact, the Philly Fed’s manufacturing employment index fell to its lowest level since May 2020. Manufacturing activity has been slow for years now.
Citation: Si J, Wang J, Dai H, Lv T, Zhao S, Chen W, Li L, Ding S and He Y (2025) Mechanistic insights into adipose-derived stem cells and exosomes in ischemia-reperfusion injury repair: from shared ...
Aligos Therapeutics Contact Jordyn Tarazi Vice President, Investor Relations & Corporate Communications +1 (650) 910-0427 [email protected] Media Contact Inizio Evoke Jake Robison Vice President ...
SOUTH SAN FRANCISCO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in ...
SOUTH SAN FRANCISCO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in ...
Marker Therapeutics, Inc. has announced a collaboration with Cellipont Bioservices to support the cGMP manufacturing of MT-601, its lead Multi-Antigen Recognizing (MAR)-T cell therapy, currently ...
Home News GlobeNewswire Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results